title: Response to Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
authors.affiliation: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. nora.straznicky@bakeridi.edu.au
authors.forename: Nora E
authors.initials: NE
authors.lastname: Straznicky
authors.forename: Elisabeth A
authors.initials: EA
authors.lastname: Lambert
authors.forename: Gavin W
authors.initials: GW
authors.lastname: Lambert
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D024821:Metabolic Syndrome / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D009765:Obesity / Q000378:metabolism*
chemical_list: D009638:Norepinephrine